Top Market Insights Stories
Market Insights
Eli Lilly expands access to weight loss drug Zepbound
By Alan GoforthAlthough the GLP-1 drug Zepbound has been shown to be effective in promoting weight loss, availability and price have been barriers to more widespread use by patients.
Market Insights
4 key barriers holding biosimilars back (and how to remove them)
Market Insights










